Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (391-400 of 442) with videos related to

Pageof 45
Sort By:
Cancer|May 14, 2026
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025Eleonora Nicolò, François Bertucci, Hamouda Boussen, et al.
Expert Review of Molecular Diagnostics|September 27, 2021
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancerUmberto Malapelle, Pasquale Pisapia, Alfredo Addeo, et al.
European Journal of Radiology|October 18, 2024
[18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastasesJana Ivanidze, Arman Sharbatdaran, Aliah McCalla, et al.
The Lancet. Oncology|May 1, 2019
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trialZefei Jiang, Wei Li, Xichun Hu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 27, 2016
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancerLei Huo, Yan Wang, Yun Gong, et al.
Cell Chemical Biology|September 15, 2021
Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancerRatika Kunder, Michelle Velyunskiy, Sara F Dunne, et al.
NPJ Precision Oncology|August 16, 2022
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclibZhou Zhu, Nicholas C Turner, Sherene Loi, et al.
Nature Communications|August 12, 2021
ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancerRokana Taftaf, Xia Liu, Salendra Singh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2025
International expert consensus on the clinical integration of circulating tumor cells in solid tumorsEleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2025
Corrigendum to "International expert consensus on the clinical integration of circulating tumor cells in solid tumors" [Eur. J. Cancer 231 (2025) 116050]Eleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.
Pageof 45

Showing results (391-400 of 442) with videos related to

Sort By:
Pageof 45
Cancer|May 14, 2026
Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025Eleonora Nicolò, François Bertucci, Hamouda Boussen, et al.
Expert Review of Molecular Diagnostics|September 27, 2021
Liquid biopsy from research to clinical practice: focus on non-small cell lung cancerUmberto Malapelle, Pasquale Pisapia, Alfredo Addeo, et al.
European Journal of Radiology|October 18, 2024
[18F]-Fluoroestradiol (FES) brain PET in the evaluation of patients with estrogen receptor positive breast cancer and known or suspected brain metastasesJana Ivanidze, Arman Sharbatdaran, Aliah McCalla, et al.
The Lancet. Oncology|May 1, 2019
Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trialZefei Jiang, Wei Li, Xichun Hu, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 27, 2016
MicroRNA expression profiling identifies decreased expression of miR-205 in inflammatory breast cancerLei Huo, Yan Wang, Yun Gong, et al.
Cell Chemical Biology|September 15, 2021
Synergistic PIM kinase and proteasome inhibition as a therapeutic strategy for MYC-overexpressing triple-negative breast cancerRatika Kunder, Michelle Velyunskiy, Sara F Dunne, et al.
NPJ Precision Oncology|August 16, 2022
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclibZhou Zhu, Nicholas C Turner, Sherene Loi, et al.
Nature Communications|August 12, 2021
ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancerRokana Taftaf, Xia Liu, Salendra Singh, et al.
European Journal of Cancer (Oxford, England : 1990)|October 31, 2025
International expert consensus on the clinical integration of circulating tumor cells in solid tumorsEleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2025
Corrigendum to "International expert consensus on the clinical integration of circulating tumor cells in solid tumors" [Eur. J. Cancer 231 (2025) 116050]Eleonora Nicolò, Carolina Reduzzi, Jean-Yves Pierga, et al.
Pageof 45